21 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/932046/mira-pharmaceuticals-announces-ketamir-2-outperforms-current-fda-approved-neuropathic-pain-treatments-gabapentin-and-pregabalin-in-preclinical-study
21 May 2024
// PHARMABIZ
17 May 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208113
24 Jan 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209883
25 Nov 2023
// ECONOMIC TIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/two-painkillers-tapentadol-and-pregabalin-may-go-off-otc-over-misuse/articleshow/105482448.cms
13 Jun 2023
// EMA
https://www.ema.europa.eu/en/documents/overview/pregabalin-sandoz-gmbh-epar-summary-public_en.pdf